Dear Editor, Methicillin-resistant Staphylococcus aureus (MRSA) is widespread in intensive care units (ICUs) [1] . Several molecular components are important for the definition and genotyping of MRSA, such as staphylococcal chromosome cassette mec (SCCmec) type, Panton-Valentine leukocidin toxin (PVL), or staphylococcal protein A (spa) production. The genotypic characteristics of hospital-acquired strains (HA-MRSA) are consistent with SCCmec type I, II, and III, without PVL production whilst community-acquired strains (CA-MRSA) often produce PVL with type IV or V SCCmec.
We report here the molecular characteristics of ICU MRSA strains between 2011 and 2013 isolated from blood cultures or respiratory samples. Sensitivity to vancomycin, daptomycin and linezolid was tested with E-test and results were interpreted according to European Committee on Antimicrobial Susceptibility Testing (EUCAST) breakpoints [2] . All samples were studied by SCCmec typing, PVL typing, and spa typing.
There were 62 MRSA strains from respiratory samples (57; 92 %) or blood (5; 8 %): overall 54 (87 %) HA-MRSA and 8 (13 %) CA-MRSA; respiratory samples accounted for 50 (93 %) and 7 (87.5 %) of HA-MRSA and CA-MRSA strains, respectively. The molecular characterization and spa typing analysis are reported in Table 1 : most MRSA had SCCmec II (35 cases, 56.4 %), of which 31 were HA-MRSA. The most common clone was t242 (50 %) and it was associated with SCCmec type II (87 %) and HA-MRSA (89 %). All isolates were susceptible to linezolid, whilst 13 and 6 isolates had a minimum inhibitory concentration (MIC) for vancomycin or daptomycin, respectively, above the EUCAST breakpoints for sensitivity. Ten of the t242 strains (32 %) had a vancomycin MIC greater than 2 mg/L, including one with a daptomycin MIC greater than 1 mg/L. The t242 strain represented 77 % (10 out of 13) of MRSA non-sensitive to vancomycin. These strains were further analyzed in order to confirm the high MIC value for vancomycin in a referral microbiology laboratory (MMARL-http://www.labmicro biologia.unict.it/). This is the first epidemiological report with t242 as the predominant strain (50 %) in Italy, with a higher frequency amongst HA-MRSA cases and associated with lower susceptibility to vancomycin. A European study in 2005-2006 of MRSA epidemiology from 19 laboratories showed that the prevalent spa types in Italy were t041 (35.8 %) and t008 (28.4 %) [3] .
All the MRSA isolates were sensitive to linezolid, the most effective drug in treating ventilator-associated pneumonia caused by MRSA. The characterization of MRSA strains with high MICs for vancomycin is important because vancomycin should be limited to selected cases, perhaps with low MICs, thereby questioning the empiric use in special settings. All the isolates were sensitive to daptomycin, confirming the microbiological activity against MRSA isolated from blood [4, 5] , even if it has no role in pneumonia. This is the first Italian report where t242 strains are predominant in the ICU setting, are mainly hospitalacquired, and associated with SCCmec II genes. These strains are characterized by an increased MIC for vancomycin, whilst susceptibility to linezolid and daptomycin is preserved. 
